SQI Diagnostics Inc. – Trademark Portfolio

Entity Type: 03

SQI Diagnostics Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SQI DIAGNOSTICS. The owner is based in Toronto.

36 Meteor Drive

Toronto M9W1A4 , CA

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SQI Diagnostics Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does SQI Diagnostics Inc. have?

SQI Diagnostics Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does SQI Diagnostics Inc. file in?

SQI Diagnostics Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SQI Diagnostics Inc.'s most well-known trademarks?

SQI Diagnostics Inc.'s registered trademark portfolio includes well-known marks such as SQI DIAGNOSTICS. These are among 1 currently registered trademark in the portfolio.

What is SQI Diagnostics Inc.'s trademark registration success rate?

SQI Diagnostics Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.